Maharshi Trivedi, Associate Professor, Pediatric Hematology Oncology and BMT at The Gujarat Cancer and Research Institute, shared a post by Indian Childhood Cancer Initiative on LinkedIn, adding:
“Blinatumomab – medicine which has changed the natural history of B ALL
- Is it available in India?
- How to access it under Humanitarian Access Program?
- Is it going to be freely available in India in future?
- What’s India’s experience?
Stay tuned.”
Quoting Indian Childhood Cancer Initiative’s post:
“Pediatric Hematology Oncology National Teaching Program on ‘Blinatumomab Humanitarian Access Program (BHAP)’ is being organized.
Date: 26th March 2026
Time: 7:00 PM onwards
Topics and Speakers:
- Blinatumomab Humanitarian Access Program (BHAP) – Dr. Caitlyn Duffy, St. Jude Hospital.
- Outpatient Blinatumomab – Dr. Revathi Raj, Apollo Hospital, Chennai.
- Indian Perspective on Blinatumomab and BHAP – Dr. (Surg Cdr) Gaurav Narula, TMH Mumbai.
Organising Committee: Dr. Satya Prakash Y., Dr. Shweta Bansal, Ponni Sivaprakasam, Dr. Arun Danewa.
We invite healthcare professionals and stakeholders to join this important knowledge-sharing session.
The link will be shared soon!”
Other articles about Blinatumomab on OncoDaily.